Chemical Communications 2012-12-07

Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy.

Guanglei Fu, Wei Liu, Shanshan Feng, Xiuli Yue

Index: Chem. Commun. (Camb.) 48(94) , 11567-9, (2012)

Full Text: HTML

Abstract

Herein, prussian blue nanoparticles, an ancient dye, were explored as a new generation of near-infrared laser-driven photothermal ablation agents for cancer therapy alternative to traditional agents due to their good photothermal efficiency and high photothermal stability but low cost and particularly clinically approved biosafety.

Related Compounds

  • Prussian blue

Related Articles:

Visible spectrophotometric method for amiodarone.

2012-01-01

[Rev. Med. Chir. Soc. Med. Nat. Iasi. 116(1) , 330-5, (2012)]

Prussian blue modified ferritin as peroxidase mimetics and its applications in biological detection.

2013-01-01

[J. Nanosci. Nanotechnol. 13(1) , 60-7, (2013)]

A branched electrode based electrochemical platform: towards new label-free and reagentless simultaneous detection of two biomarkers.

2013-02-04

[Chem. Commun. (Camb.) 49(11) , 1052-4, (2013)]

Folate grafted Prussian Blue entrapped with gadolinium(III) as a new contrast agent for tumor-targeted magnetic resonant imaging.

2013-08-01

[J. Nanosci. Nanotechnol. 13(8) , 5233-9, (2013)]

Controllable growth of Prussian blue nanostructures on carboxylic group-functionalized carbon nanofibers and its application for glucose biosensing.

2012-11-16

[Nanotechnology 23(45) , 455502, (2012)]

More Articles...